Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Pegfilgrastim in Preventing Chemotherapy-induced Neutropenia
NCT01918241Phase 2Unknown
- Sponsor
- Jiuyuan Gene Engineering
- Start
- Jul 2013
- Primary completion
- Jan 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pegfilgrastim in neutropenia, sponsored by Jiuyuan Gene Engineering. Status: unknown.
02
Drugs
pegfilgrastim
03
Conditions
neutropenia
Beyond the preview
Go deeper on NCT01918241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01918241.